Bruker's Microbiology and Infection diagnostics division announces an expansion of its validated Polymerase Chain Reaction (PCR) assays on the BeGenius® sample-to-answer molecular diagnostics system at ESCMID 2025.
Artificial intelligence streamlines the optimisation of bioprinting parameters for oral soft tissue grafts, reducing time and resource demands while enabling efficient, personalised dental treatments.
Athens, 10th February: The IDEAL Project has officially launched in Athens with its first Consortium Meeting, led by the University of the Aegean. This pioneering EU-funded initiative is set to transform democratic participation by addressing one of Europe’s greatest challenges - language barriers in political engagement.
A recent study explained the mechanisms by which pulsed electromagnetic field therapy enhances doxorubicin uptake, paving the way for precision-driven cancer therapies with fewer side effects
N4 Pharma Plc the specialist preclinical stage biotech company announces a new lead programme, N4 101. This orally-delivered inflammation inhibitor for Irritable Bowel Disease (IBD) uses Nuvec®, the company’s novel silica non-viral, non-lipid nanoparticle delivery system, to overcome the challenges with current IBD treatments.
Linkam's updated CMS196V4 stage features an improved user interface with a touch-panel and joystick, an encoded and motorised XY stage and a newly interchangeable optical bridge for imaging, amongst other updated features. It enables researchers to investigate samples at cryogenic temperatures down to < -195 °C with ease.
Satisfied Users & 
Approved Press Releases
